5-Methoxy-3,3'-bipyridine

Catalog No.: 
ACRZSC212
CAS No.: 
1190645-04-5
Molecular Formula: 
C11H10N2O
Molecular Weight: 
186.21
5-Methoxy-3,3'-bipyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$449.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methoxy-3,3'-bipyridine
IUPAC Name5-methoxy-3,3'-bipyridine
MDL No.MFCD15475921
Molecular FormulaC11H10N2O
Molecular Weight186.21
SMILESCOC1=CN=CC(C2=CC=CN=C2)=C1
InChI KeyMESIWFACISTOID-UHFFFAOYSA-N
Synonym5-methoxy-3,3'-bipyridine;3,3'-Bipyridine, 5-methoxy-
CAS No.1190645-04-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRZSC212 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKSW571 route compound structure diagram
    ACNKSW57150720-12-2In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACRZSC212 route product structure diagram
    ACRZSC2121190645-04-5
Inquiry

2. ACRZSC212 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBQAI075 route compound structure diagram
    ACBQAI075873302-36-4In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACRZSC212 route product structure diagram
    ACRZSC2121190645-04-5
Inquiry

3. ACRZSC212 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGADK973 route compound structure diagram
    ACGADK973329214-79-1In Stock
  2. Plus
  3. ACNKSW571 route compound structure diagram
    ACNKSW57150720-12-2In Stock
  4. Then
  5. ACRZSC212 route product structure diagram
    ACRZSC2121190645-04-5
Inquiry

Comments (0)